共 87 条
- [1] Metra M(2017)Heart failure Lancet 390 1981-1995
- [2] Teerlink JR(2017)Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the American Heart Association Circulation 135 e1054-e91
- [3] Chow SL(2013)B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 1498-1506
- [4] Maisel AS(2016)Prognostic implications of changes in N‑terminal pro-B-type natriuretic peptide in patients with heart failure J Am Coll Cardiol 68 2425-2436
- [5] Anand I(2006)Direct comparison of B‑type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data Clin Chem 52 1528-1538
- [6] van Veldhuisen DJ(2008)Pro-B-type natriuretic peptide levels in acute decompensated heart failure J Am Coll Cardiol 51 1874-1882
- [7] Linssen GCM(2011)Direct comparison of serial B‑type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure Crit Care 15 R1-3411
- [8] Jaarsma T(2013)Comparison of the diagnostic and prognostic values of B‑type and atrial-type natriuretic peptides in acute heart failure Int J Cardiol 168 3404-233
- [9] Zile MR(2004)Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure Eur J Heart Fail 6 227-324
- [10] Claggett BL(2008)Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Arch Intern Med 168 316-794